Skip to main navigation
Supernus Pharmaceuticals

Header Links

  • Return to Supernus.com

Investor Relations

  • Overview
  • News & Events
    Press Releases Events & Presentations
  • Governance
    Corporate Governance Management Board of Directors Committee Composition Contact the Board
  • Financials & Filings
    Financials & Filings SEC Filings Annuals & Proxies Quarterly Results
  • Stock
    Stock Information Historic Stock Lookup Investment Calculator Ownership Profile
  • Contact Us

Investor Relations

  • Overview
  • News & Events
    • Press Releases
    • Events & Presentations
  • Governance
    • Corporate Governance
    • Management
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Financials & Filings
    • Financials & Filings
    • SEC Filings
    • Annuals & Proxies
    • Quarterly Results
  • Stock
    • Stock Information
    • Historic Stock Lookup
    • Investment Calculator
    • Ownership Profile
  • Contact Us

    Breadcrumb

  1. Investor Relations
  2. Press Releases

Press Releases

Date Title  
September 27, 2023
Supernus Pharmaceuticals Announces Webcast of R&D Day to be Held on October 18, 2023 in New York City
PDF Version
September 9, 2023
Supernus Announces New Qelbree® Data Showing Improvement in ADHD Symptoms
PDF Version
August 31, 2023
Supernus to Participate in the Wells Fargo Healthcare Conference
PDF Version
August 21, 2023
Bethany L. Sensenig Joins Supernus’ Board of Directors
PDF Version
August 8, 2023
Supernus Announces Second Quarter 2023 Financial Results
PDF Version
July 24, 2023
Supernus Pharmaceuticals to Announce Second Quarter 2023 Financial Results and Host Conference Call on August 8, 2023
PDF Version
May 31, 2023
Supernus to Participate in the Jefferies Healthcare Conference
PDF Version
May 9, 2023
Supernus Announces First Quarter 2023 Financial Results
PDF Version
May 2, 2023
Supernus to Present at the Bank of America 2023 Health Care Conference
PDF Version
April 25, 2023
Supernus Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call on May 9, 2023
PDF Version

Pagination

  • Current page 1
  • Page 2
  • Next page next ›
  • Last page last »
Displaying 1 - 10 of 16

Shareholder Tools


Email Alerts


RSS Feeds


Search

Back to Top
Supernus Pharmaceuticals

Supernus Pharmaceuticals, Inc.
9715 Key West Avenue
Rockville, MD 20850
(301) 838-2500
info@supernus.com

Back to Top

© 2023 Supernus Pharmaceuticals

Post Footer Links

  • Sitemap
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • State Policy
  • Social Media Community Guidelines